Trilogy Investment Funds plc offers a family of Funds to eligible investors. Funds are available in the following disciplines: Emerging Markets Equity, Emerging Wealth Equity, Global Equity, and the Valant Series Emerging Markets. Please see below for more information on the Trilogy Investment Funds.
Trilogy Emerging Markets Fund
The investment objective of the Fund is to provide investors with a rate of return (after fees and expenses and before taxes) which exceeds the return of the Benchmark.
The Fund will usually hold between 70 and 120 securities and its main investments will include equities, securities convertible into equities, securities with equity characteristics, including, but not limited to, American Depositary Receipts, Global Depositary Receipts, participation notes, local access products, IPO investments and preferred stocks and warrants (which are considered as equity equivalents). The Fund will invest in a portfolio of securities and cash in order to achieve its investment objective. The Fund's focus will be on listed global companies that are generally included in the Benchmark which the Investment Manager considers to have the potential to grow earnings over the medium to long-term. At any point and time the Fund will be invested in at least 10 countries.
Trilogy Emerging Wealth Fund
The Fund seeks long-term growth of capital through investments primarily in the equity securities of companies which may be located in either developed or emerging markets and which are exposed to, and derive revenue or profits from, emerging market countries.
Under normal market conditions, the Fund will usually hold between 60 and 100 securities. The Fund's focus will be on companies that are either traded on Recognized Markets in emerging market countries which the Investment Manager considers to have the potential to grow earnings over the medium to long-term from strong domestic demand, or are traded on Recognized Markets in developed market countries which have the potential to derive a high level of sales or revenues and profits from emerging markets.
Valant Series Emerging Markets Fund
The Fund seeks long-term growth of capital and will primarily invest in equity securities of emerging market issuers in order to achieve its investment objective.
The Fund will invest, in normal market conditions, at least 80% of its net assets in securities of emerging market issuers that are primarily traded on Recognized Markets based on a multi-factor quantitative model. The quantitative bottom-up stock selection model seeks to identify emerging markets securities to purchase for the Fund based on various company-specific characteristics including: valuation, profitability, quality, momentum and volatility. The model incorporates macro-economic and financial market conditions in determining the relative weights of the various company specific characteristics that are being applied at a given point in time. The Fund may sell securities for a variety of reasons, such as to secure gains, limit losses or redeploy assets into more promising opportunities.
Terms and Conditions
The information contained herein is not for distribution to and does not constitute an offer to sell or solicitation of any offer to buy any securities in the United States of America to or for the benefit of any United States person(s). This material is neither a solicitation or an offer or a recommendation to buy or sell investment products or to engage in other transactions.
Additional Information for German Investors
For the following Sub-Funds, no notification for marketing in the Federal Republic of Germany has been filed with the Federal Financial Supervisory Authority (BaFin), so that units of the following investment compartments may not be marketed to investors within the jurisdiction of the German Capital Investment Code:
•Trilogy Emerging Wealth Fund
•The Valant Series Emerging Markets Fund